Aminoglycosides: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "==Source==" to "==References== <references/>") |
Neil.m.young (talk | contribs) (Text replacement - "* " to "*") |
||
| Line 1: | Line 1: | ||
* Gentamicin, amikacin, streptomycin (either alone or with B-lactam) | *Gentamicin, amikacin, streptomycin (either alone or with B-lactam) | ||
** Serious gram-negative bacillary infections | **Serious gram-negative bacillary infections | ||
*** Ill patient with pyelonephritis | ***Ill patient with pyelonephritis | ||
*** Meningitis (due to Pseudomonas, Acinetobacter) | ***Meningitis (due to Pseudomonas, Acinetobacter) | ||
*** Peritoneal Dialysis–Associated Peritonitis | ***Peritoneal Dialysis–Associated Peritonitis | ||
*** Bacterial endocarditis? | ***Bacterial endocarditis? | ||
* Caution: Use in patients with Myasthenia Gravis, can precipitate crisis | *Caution: Use in patients with Myasthenia Gravis, can precipitate crisis | ||
==See Also== | ==See Also== | ||
Revision as of 23:01, 4 July 2016
- Gentamicin, amikacin, streptomycin (either alone or with B-lactam)
- Serious gram-negative bacillary infections
- Ill patient with pyelonephritis
- Meningitis (due to Pseudomonas, Acinetobacter)
- Peritoneal Dialysis–Associated Peritonitis
- Bacterial endocarditis?
- Serious gram-negative bacillary infections
- Caution: Use in patients with Myasthenia Gravis, can precipitate crisis
See Also
References
Goodman & Gilman's Pharmacology
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||